top of page

News

Pi-Cardia Receives FDA Breakthrough Device Designation for ShortCut™

BUSINESSWIRE

Pi-Cardia Successfully Completes Enrollment in Pivotal Study for ShortCut™

BUSINESSWIRE

Pi-Cardia Hires Gary Gratson to Lead Global Commercialization

BUSINESSWIRE

First US Patient Successfully Treated with ShortCut™

ACCESSWIRE

Pi-Cardia Successfully Performs Mitral Valve Splitting With ShortCut™

ACCESSWIRE

Pi-Cardia Receives FDA IDE Approval for Pivotal Study with ShortCut™ Device

ACCESSWIRE

First Dedicated Transcatheter Leaflet Splitting Device:
The ShortCut Device

EuroIntervention

News

Pi-Cardia ShortCut™ Device Successfully Treats First Patients in Europe

ACCESSWIRE

Pi-Cardia: Repair Rather than Replacement in TAVR

MedTech STRATEGIST

Leaflex: Changing the Conversation Around Aortic Stenosis?

Cardiovascular News

Pi-Cardia Successfully Treats First Patients with ShortCut™ Device

Businesswire

Press release - Venus Medtech to Partner With Pi-Cardia to Bring Its Leaflex™ Aortic Valve Technology to China

PRNewswire

Press release - Pi-Cardia Closes a $27 Million Financing led by Sofinnova Partners to Continue Clinical Trials with its Leaflex™ Aortic Valve Technology

Yahoo finance

Press release - Pi-Cardia Appoints Prof. Jacques Séguin
As Chairman

PRNewswire

TVT 2019:
Clinical Experiences with Pi-Cardia Leaflex Aortic Valve Remodeling: An Alternative to TAVR in Some Patients?

Dr. Martin B. Leon

PCR 2019:
Safety, Feasibility and Acute Performance of the Leaflex™
Performer when Used Pre TAVI in Aortic Stenosis Patients.
The Leaflex™ Performer Feasibility Study

Prof. Andreas Baumbach

Pi-Cardia’s Leaflex treatment improves aortic stenosis more than balloon valvuloplasty

BioWorld MedTech

Valve Leaflet Scoring Device for Aortic Stenosis Clears Feasibility Hurdle

tctMD/ the heart beat

Press release -Pi-Cardia First in Human Study Shows Significant Improvement in Aortic Valve Function Following Treatment with its Novel Non-Implant Based Leaflex™ Catheter

Yahoo finance

Press release -Pi-Cardia Successfully Completes
First in Human Studies with Novel Non-Implant Based
Treatment of Aortic Stenosis

Yahoo finance

TCT 2018: Innovation Gone Wild: The Pi-Cardia Leaflex™ Aortic Valve Remodeling System

Dr. Philippe Genereux

SHDS 2018: Pi-Cardia Leaflex™ Aortic Valve Remodeling: Experimental Findings and Early Human Experiences

Dr. Darren Mylotte

PCR 2017 Innovators Day: Pi-Cardia Leaflex™ performer

Prof. Andreas Baumbach

PCR 2016 Innovators Day: Pi-Cardia Leaflex™ Technology

Dr. Philippe Genereux

Press release - Pi-Cardia raises $10m

“Globes”- Israel business news

BACK TO TOP

bottom of page